Top

Cardiovascular Diabetology

Published in:

Open Access 01-12-2011 | Original investigation

Decreased adiponectin and increased inflammation expression in epicardial adipose tissue in coronary artery disease

Authors: Yuan Zhou, Yutao Wei, Lei Wang, Xianguo Wang, Xinling Du, Zongquan Sun, Nianguo Dong, Xinzhong Chen

Published in: Cardiovascular Diabetology | Issue 1/2011

Abstract

Background

Disorders of endocrine substances in epicardial adipose tissue are known causes of coronary artery disease (CAD). Adiponectin is associated with cardiovascular disease. However, expression of adiponectin in epicardial adipose tissue and its function in CAD pathogenesis is unclear. This study investigates adiponectin expression in epicardial adipose tissue in CAD patients.

Methods

Vessels or adipose tissue samples collected from CAD patients and non-CAD controls were examined after immunochemical staining. Adiponectin, cytokines of interleukin-6 (IL-6) and necrosis factor-α (TNF-α) and toll-like receptor 4 (TLR4) expression level in adipose tissue were measured using real-time quantitative RT-PCR. Adiponectin concentrations in peripheral and coronary sinus vein plasma were measured with enzyme-linked immunosorbent assay. Peripheral vein plasma biochemistries were performed with routine laboratory techniques. Monocytes were collected from blood using lymphocyte separation medium. Expression level of cytokines and transcription factor NF-κB were measured to learn the effect of adiponectin on stearic acid-stimulated monocytes. Percentage of TLR4 positive monocytes was analyzed using flow cytometry.

Results

Histological examination revealed increased macrophage infiltration into epicardial adipose tissue of CAD patients. Decreased adiponectin displayed by real-time quantitative RT-PCR was associated with enhanced cytokines of IL-6 and TNF-α or TLR4 expression level in epicardial adipose tissue, suggesting decreased circulating adiponectin may be useful as a more sensitive predictor for coronary atherosclerosis than routine laboratory examinations. Adiponectin suppressed secretion of IL-6 and TNF-α in stimulated monocytes and TLR4 was expressed on cell surfaces.

Conclusions

Endocrine disorders in epicardial adipose tissue are strongly linked to CAD, and adiponectin has a protective effect by inhibiting macrophage-mediated inflammation.

Available only for authorised users

Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM: Positional cloning of the mouse obese gene and its human homologue. Nature. 1994, 372: 425-432. 10.1038/372425a0.CrossRefPubMed

Scherer P, Williams S, Fogliano M, Baldini G, Lodish HF: A novel serum protein similar to C1q, produced exclusively in adipocytes. J Biol Chem. 1995, 270: 26746-26749. 10.1074/jbc.270.45.26746.CrossRefPubMed

Steppan CM, Bailey ST, Bhat S, Brown EJ, Banergee RR, Wright CM, Patel HR, Ahima RS, Lazar MA: The hormone resistin links obesity to diabetes. Nature. 2001, 409: 307-312. 10.1038/35053000.CrossRefPubMed

Samad F, Loskutoff DJ: Tissue distribution and regulation of plasminogen activator inhibitor-1 in obese mice. Mol Med. 1996, 2: 568-582.PubMedCentralPubMed

Alessi M, Peiretti F, Morange P, Henry M, Nalbone G, Juhan-Vague I: Production of plasminogen activator inhibitor 1 by human adipose tissue: possible link between visceral fat accumulation and vascular disease. Diabetes. 1997, 46: 860-867. 10.2337/diabetes.46.5.860.CrossRefPubMed

Kleinz MJ, Davenport AP: Emerging roles of apelin in biology and medicine. Pharmacol Ther. 2005, 107: 198-211. 10.1016/j.pharmthera.2005.04.001.CrossRefPubMed

Xu H, Uysal KT, Becherer JD, Arner P, Hotamisligil GS: Altered tumor necrosis factor-alpha (TNF-alpha) processing in adipocytes and increased expression of transmembrane TNF-alpha in obesity. Diabetes. 2002, 51: 1876-1883. 10.2337/diabetes.51.6.1876.CrossRefPubMed

Nonogaki K, Fuller GM, Fuentes NL, Moser AH, Staprans I, Grunfeld C, Feingold KR: Interleukin-6 stimulates hepatic triglyceride secretion in rats. Endocrinology. 1995, 136: 2143-2149. 10.1210/en.136.5.2143.PubMed

Iacobellis G, Corradi D, Sharma AM: Epicardial adipose tissue: anatomic, biomolecular and clinical relationships with the heart. Nat Clin Pract Cardiovasc Med. 2005, 2: 536-543. 10.1038/ncpcardio0319.CrossRefPubMed

10.

Mathieu P, Pibarot P, Larose E, Poirier P, Marette A, Després JP: Visceral obesity and the heart. Int J Biochem Cell Biol. 2008, 40: 821-836. 10.1016/j.biocel.2007.12.001.CrossRefPubMed

11.

Canoy D: Distribution of body fat and risk of coronary heart disease in men and women. Curr Opin Cardiol. 2008, 23: 591-598. 10.1097/HCO.0b013e328313133a.CrossRefPubMed

12.

Matsuda M, Shimomura I, Sata M, Arita Y, Nishida M, Maeda N, Kumada M, Okamoto Y, Nagaretani H, Nishizawa H, Kishida K, Komuro R, Ouchi N, Kihara S, Nagai R, Funahashi T, Matsuzawa Y: Role of adiponectin in preventing vascular stenosis. The missing link of adipo-vascular axis. J Biol Chem. 2002, 277: 37487-37491. 10.1074/jbc.M206083200.CrossRefPubMed

13.

Antoniades C, Antonopoulos AS, Tousoulis D, Stefanadis C: Adiponectin: from obesity to cardiovascular disease. Obes Rev. 2009, 10: 269-279. 10.1111/j.1467-789X.2009.00571.x.CrossRefPubMed

14.

Holness CL, Simmons DL: Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood. 1993, 81: 1607-1613.PubMed

15.

Iacobellis G, di Gioia CR, Cotesta D, Petramala L, Travaglini C, De Santis V, Vitale D, Tritapepe L, Letizia C: Epicardial adipose tissue adiponectin expression is related to intracoronary adiponectin levels. Horm Metab Res. 2009, 41: 227-231. 10.1055/s-0028-1100412.CrossRefPubMed

16.

Zhang D, Hetherington C, Tan S, Dziennis S, Gonzalez D, Chen H, Tenen D: Sp1 is a critical factor for the monocytic specific expression of human CD14. J Biol Chem. 1994, 269: 11425-11434.PubMed

17.

Yudkin J, Kumari M, Humphries S, Mohamed-Ali V: Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link?. Atherosclerosis. 2000, 148: 209-214. 10.1016/S0021-9150(99)00463-3.CrossRefPubMed

18.

Fruebis J, Tsao T, Javorschi S, Ebbets-Reed D, Erickson M, Yen F, Bihain B, Lodish H: Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA. 2001, 98: 2005-2010. 10.1073/pnas.041591798.PubMedCentralCrossRefPubMed

19.

Baker AR, Silva NF, Quinn DW, Harte AL, Pagano D, Bonser RS, Kumar S, Mcternan PG: Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol. 2006, 5: 1-7. 10.1186/1475-2840-5-1.PubMedCentralCrossRefPubMed

20.

Suganami T, Mieda T, Itoh M, Shimoda Y, Kamei Y, Ogawa Y: Attenuation of obesity-induced adipose tissue inflammation in C3H/HeJ mice carrying a Toll-like receptor 4 mutation. Biochem Biophys Res Commun. 2007, 354: 45-49. 10.1016/j.bbrc.2006.12.190.CrossRefPubMed

21.

Coenen K, Gruen M, Lee-Young R, Puglisi MJ, Wasserman DH, Hasty AH: Impact of macrophage toll-like receptor 4 deficiency on macrophage infiltration into adipose tissue and the artery wall in mice. Diabetologia. 2009, 52: 318-328. 10.1007/s00125-008-1221-7.PubMedCentralCrossRefPubMed

22.

Newby AC, George SJ, Ismail Y, Johnson JL, Sala-Newby GB, Thomas AC: Vulnerable atherosclerotic plaque metalloproteinases and foam cell phenotypes. Thromb Haemost. 2009, 101: 1006-1011.PubMedCentralPubMed

23.

Nakano Y, Tobe T, Choi-Miura NH, Mazda T, Tomita M: Isolation and characterization of GBP28, a novel gelatin-binding protein purified from human plasma. J Biochem. 1996, 120: 803-812.CrossRefPubMed

24.

Maeda K, Okubo K, Shimomura I, Funahashi T, Matsuzawa Y, Matsubara K: cDNA cloning and expression of a novel adipose specific collagen-like factor, ApM 1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun. 1996, 221: 286-289. 10.1006/bbrc.1996.0587.CrossRefPubMed

25.

Saito K, Tobe T, Minoshima S, Asakawa S, Sumiya J, Yoda M, Nakano Y, Shimizu N, Tomita M: Organization of the gene for gelatin-binding protein (GBP28). Gene. 1999, 229: 67-73. 10.1016/S0378-1119(99)00041-4.CrossRefPubMed

26.

Tuttolomondo A, La Placa S, Di Raimondo D, Bellia C, Caruso A, Lo Sasso B, Guercio G, Diana G, Ciaccio M, Licata G, Pinto A: Adiponectin, resistin and IL-6 plasma levels in subjects with diabetic foot and possible correlations with clinical variables and cardiovascular co-morbidity. Cardiovasc Diabetol. 2010, 9: 50-10.1186/1475-2840-9-50.PubMedCentralCrossRefPubMed

27.

Shibata R, Ouchi N, Murohara T: Adiponectin and cardiovascular disease. Circ J. 2009, 73: 608-614. 10.1253/circj.CJ-09-0057.CrossRefPubMed

28.

Cheng KH, Chu CS, Lee KT, Lin TH, Hsieh CC, Chiu CC, Voon WC, Sheu SH, Lai WT: Adipocytokines and proinflammatory mediators from abdominal and epicardial adipose tissue in patients with coronary artery disease. Int J Obes (Lond). 2008, 32: 268-274. 10.1038/sj.ijo.0803726.CrossRef

29.

Iacobellis G, Cotesta D, Petramala L, De Santis V, Vitale D, Tritapepe L, Letizia C: Intracoronary adiponectin levels rapidly and significantly increase after coronary revascularization. Int J Cardiol. 2010, 144: 160-163. 10.1016/j.ijcard.2008.12.155.CrossRefPubMed

30.

Park JS, Ahn SG, Hwang JW, Lim HS, Choi BJ, Choi SY, Yoon MH, Hwang GS, Tahk SJ, Shin JH: Impact of body mass index on the relationship of epicardial adipose tissue to metabolic syndrome and coronary artery disease in an Asian population. Cardiovasc Diabetol. 2010, 9: 29-10.1186/1475-2840-9-29.PubMedCentralCrossRefPubMed

31.

Febbraio M, Silverstein RL: CD36: implications in cardiovascular disease. Int J Biochem Cell Biol. 2007, 39: 2012-2030. 10.1016/j.biocel.2007.03.012.PubMedCentralCrossRefPubMed

32.

Lemieux I, Poirier P, Bergeron J, Almeras N, Lamarche B, Cantin B, Dagenais GR, Despres JP: Hypertriglyceridemic waist: a useful screening phenotype in preventive cardiology?. Can J Cardiol. 2007, 23 (Suppl B): 23B-31B.PubMedCentralCrossRefPubMed

33.

Almeda-Valdes P, Cuevas-Ramos D, Mehta R, Gomez-Perez FJ, Cruz-Bautista I, Arellano-Campos O, Navarrete-Lopez M, Aguilar-Salinas CA: Total and high molecular weight adiponectin have similar utility for the identification of insulin resistance. Cardiovasc Diabetol. 2010, 9: 26-10.1186/1475-2840-9-26.PubMedCentralCrossRefPubMed

Title: Decreased adiponectin and increased inflammation expression in epicardial adipose tissue in coronary artery disease
Authors: Yuan Zhou
Yutao Wei
Lei Wang
Xianguo Wang
Xinling Du
Zongquan Sun
Nianguo Dong
Xinzhong Chen
Publication date: 01-12-2011
Publisher: BioMed Central
Published in: Cardiovascular Diabetology / Issue 1/2011
Electronic ISSN: 1475-2840
DOI: https://doi.org/10.1186/1475-2840-10-2

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2011

Effects of aleglitazar, a balanced dual peroxisome proliferator-activated receptor α/γ agonist on glycemic and lipid parameters in a primate model of the metabolic syndrome

"The metabolic syndrome... is dead": These reports are an exaggeration

The effect of cardiovascular risk factors on the longitudinal evolution of the carotid intima medial thickness in children with type 1 diabetes mellitus

Association of ADIPOR2 gene variants with cardiovascular disease and type 2 diabetes risk in individuals with impaired glucose tolerance: the Finnish Diabetes Prevention Study

Nicorandil prevents endothelial dysfunction due to antioxidative effects via normalisation of NADPH oxidase and nitric oxide synthase in streptozotocin diabetic rats

The association between glucometabolic disturbances, traditional cardiovascular risk factors and self-rated health by age and gender: A cross-sectional analysis within the Malmö Preventive Project

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

At a glance: The STEP trials